Selective Genetics Inc.

The success of Abbott Laboratories' acquisition of Spinal Concepts may depend as much on company restraint as on company resources. By David Cassak Jeffrey Binder, president of Austin, TX-based Spina

Regulating inter-bacterial communication to prevent infection Quorum sensing, or the control of gene expression in response to cell density, is used by a wide variety of bacteria—both Gram-negative an

A new biological treatment for coronary artery disease looms on the horizon. Will cardiovascular devices help the biotechnology approaches deliver? by Mary Stuart In February, Genentech Inc. delive

More than a decade after they were first formed, gene therapy companies are still largely university research organizations in commercial disguise. When gene therapy companies first got started, scien